Firefly Neuroscience (AIFF) Cash from Operations (2010 - 2026)

Firefly Neuroscience's Cash from Operations history runs 17 years deep, the most recent figure standing at 1948000.0 for Q1 2026.

• On a quarterly basis, Cash from Operations rose 22.42% year-over-year to 1948000.0 in Q1 2026; TTM through Mar 2026 was 7631000.0, a 31.77% increase from a year earlier, with the FY2025 full-year figure at 8194000.0, down 33.13% from the prior year.
• Cash from Operations declined to 1948000.0 in Q1 2026 per AIFF's latest filing, from 1805000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 290130.0 in Q3 2022 and bottomed at 4937000.0 in Q3 2024.
• The 5-year median for Cash from Operations is 1646500.0 (2025), against an average of 1687622.56.
• Across the five-year window, Cash from Operations soared 193.69% in 2022 and tumbled 2349.27% in 2024, its largest moves.
• Year by year, Cash from Operations stood at 3244482.0 in 2022, then surged by 84.28% to 510000.0 in 2023, then tumbled by 868.04% to 4937000.0 in 2024, then soared by 63.44% to 1805000.0 in 2025, then fell by 7.92% to 1948000.0 in 2026.
• Per Business Quant, the three latest AIFF Cash from Operations figures stand at 1948000.0 (Q1 2026), 1805000.0 (Q4 2025), and 1488000.0 (Q3 2025).